Loading...
Hogy Medical Co.,Ltd.
HGYMF•PNK
Healthcare
Medical - Instruments & Supplies
$24.34
$0.00(0.00%)
Hogy Medical Co.,Ltd. (HGYMF) Financial Performance & Income Statement Overview
Review Hogy Medical Co.,Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.10%
↑ 0.10%
Operating Income Growth
-17.01%
↓ 17.006%
Net Income Growth
-45.79%
↓ 45.79%
Operating Cash Flow Growth
65.22%
↑ 65.22%
Operating Margin
9.74%
↑ 9.74%
Gross Margin
32.25%
↑ 32.25%
Net Profit Margin
3.89%
↑ 3.89%
ROE
1.95%
↑ 1.95%
ROIC
4.35%
↑ 4.35%
Hogy Medical Co.,Ltd. (HGYMF) Income Statement & Financial Overview
Review Hogy Medical Co.,Ltd.'s (HGYMF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $9.12B | $10.40B | $9.89B | $9.72B |
| Cost of Revenue | $6.40B | $6.86B | $6.94B | $6.32B |
| Gross Profit | $2.72B | $3.54B | $2.96B | $3.40B |
| Gross Profit Ratio | $0.30 | $0.34 | $0.30 | $0.35 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $2.34B | $2.22B | $2.21B | $2.07B |
| Operating Expenses | $2.44B | $2.21B | $2.21B | $2.07B |
| Total Costs & Expenses | $8.84B | $9.07B | $9.15B | $8.39B |
| Interest Income | $58.00M | $33.00M | $58.00M | $65.00M |
| Interest Expense | $26.00M | $0.00 | $17.00M | $6.00M |
| Depreciation & Amortization | $1.50B | $1.41B | $1.42B | $1.41B |
| EBITDA | $1.91B | $2.74B | $2.30B | $2.74B |
| EBITDA Ratio | $0.21 | $0.26 | $0.23 | $0.28 |
| Operating Income | $283.00M | $1.32B | $747.00M | $1.33B |
| Operating Income Ratio | $0.03 | $0.13 | $0.08 | $0.14 |
| Other Income/Expenses (Net) | -$1.18B | -$92.00M | $452.00M | $66.00M |
| Income Before Tax | -$898.00M | $1.23B | $1.20B | $1.40B |
| Income Before Tax Ratio | -$0.10 | $0.12 | $0.12 | $0.14 |
| Income Tax Expense | $318.00M | $362.00M | $338.00M | $395.00M |
| Net Income | -$1.22B | $869.00M | $861.00M | $1.006B |
| Net Income Ratio | -$0.13 | $0.08 | $0.09 | $0.10 |
| EPS | -$52.93 | $40.32 | $39.12 | $41.44 |
| Diluted EPS | -$52.93 | $40.32 | $39.12 | $41.44 |
| Weighted Avg Shares Outstanding | $22.98M | $21.55M | $22.01M | $24.27M |
| Weighted Avg Shares Outstanding (Diluted) | $22.98M | $21.55M | $22.01M | $24.27M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan